SCHEMBL7953288

SCHEMBL7953288

CCOC(=O)C1(S(=O)(=O)c2ccc(Oc3ccccc3Cl)cc2)CCN(Cc2ccccc2)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.75
KMT2A Q03164 3/20 0.75
ALDH1A1 P00352 2/20 0.75
SMN1; SMN2 Q16637 2/20 0.75
CYP3A4 P08684 2/20 0.74
CYP2D6 P10635 2/20 0.74
CYP2C9 P11712 2/20 0.74
CYP2C19 P33261 2/20 0.74
HTT P42858 2/20 0.69
LMNA P02545 1/20 0.69
GAA P10253 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
CYP1A2 P05177 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
MMP1 P03956 14/20 0.58
MMP9 P14780 14/20 0.58
MMP13 P45452 14/20 0.58
ADAM17 P78536 14/20 0.58
ADAMTS4 O75173 1/20 0.58
MMP2 P08253 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410572 0.90 ALDH1A1 (0.90) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6565432 0.86 CYP3A4 (0.84) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL7415470 0.85 CYP3A4 (0.80) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6567108 0.84 CYP3A4 (0.79) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL7408152 0.81 CYP3A4 (0.74) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6568555 0.81 MMP1 (0.76) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6566808 0.81 CYP3A4 (0.80) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL6263497 0.81 ADAM17 (0.76) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL7411339 0.81 MMP1 (0.76) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4
SCHEMBL7410569 0.80 MMP1 (0.66) MEN1KMT2AALDH1A1SMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331563-B1 LOW MOLECULAR WEIGHT, NON-PEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES AND TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME; TREATING ARTHRITIS, TUMOR METASTASIS, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, INSULIN RESISTANCE WYETH HOLDINGS CORPORATION 2001-12-18 US disclosed